8-K BridgeBio Oncology Therapeutics, Inc. 2026-09-08: filing_filed_at
| Value | {"value": "2026-09-08T16:19:06", "timezone": "US/Eastern (EDGAR acceptance, as filed)"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K BridgeBio Oncology Therapeutics, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1869105/000119312526385225/0001193125-26-385225-in
Retrieved: 2026-09-08T22:35:03.402228+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/74a6fed6-cf19-44fc-90d9-e9d3e93b6b0b
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1869105/000119312526385225/0001193125-26-385225-in
Retrieved: 2026-09-08T22:35:03.402228+02:00
Raw response sha256:
39804be03386021c5b46eba8dd8971dc…Cite as: FACTANKER, https://factanker.com/fact/74a6fed6-cf19-44fc-90d9-e9d3e93b6b0b
History
- no predecessors — first report